OpenResearchAlpha

JNCI Cancer Spectrum · 18 Nov 2026

“Time is of the essence”: physician challenges impact patient access to chimeric antigen receptor T-cell therapy

Haley Newman, Anna Sparrow, Kerry Coughlin, Melissa P Beauchamin, Kira Bona, Lucy Cain, Amanda Dinofia, Stephen Grupp, Colleen Kelly, Shannon Maude, Regina Myers, Susan K Parsons, Susan R Rheingold, Sarah K Tasian, Claire White, Daniel J Zheng, Allison Barz Leahyh-index 19

0
Citations
no database records one yet
0
Citations in 2026
so far
19
Leading author's h-index
Allison Barz Leahy, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract Background CD19-directed chimeric antigen receptor T-cell therapy (CART) is a life-saving regimen for children with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL), yet children from lower socioeconomic and historically marginalized backgrounds are less likely to receive it. Understanding the provider experience of CART referral and post-CART clinical management is critical for designing effective interventions to improve access. Objective To explore physicians’ experiences identifying and referring pediatric patients with r/r B-ALL for CART across diverse hospital settings, and to identify physician-perceived facilitators and barriers to CART treatment. Study Design Focus groups using a semi-structured guide were conducted with pediatric oncology physicians, recruited via email and at a national conference, with targeted recruitment of National Cancer Institute Community Oncology Research Program (NCORP) site providers. Questions explored identifying pediatric patients with r/r B-ALL as CART candidates, referring them for CART, and accessing institutional infrastructure to support referral. Results Analysis revealed six domains spanning referral to CART and subsequent CART treatment: identification of potentially eligible patients; complexity of CART referral; barriers to insurance approval; physician perception of patients’ social/financial circumstances; and variability in pre- and post-CART management guidelines. Health system-level facilitators and barriers included patient identification and referral processes to tertiary care centers, guidelines for bridging therapy and post-CART toxicity management, and navigation support for patient care and insurance approval. Conclusion Findings highlight challenges in community-based settings where resources, infrastructure and geographic availability for CART are variable. Standardizing referral pathways, centralizing trial information, and streamlining CART-center intake process and communication are of immediate importance.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Allison Barz Leahy has the highest h-index among the authors (19).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (17)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.
“Time is of the essence”: physician challenges impact patient access to chimeric antigen receptor T-cell therapy - QAI OpenResearch